WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Bicara Therapeutics revenue was $0.00 for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $0.0, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BCAX annual revenue was $0.0, with N/A growth year-over-year.

BCAX revenue history

Current Revenue
$0.0
Current Earnings
-$68.0M
Current Profit Margin
0%

Be the first to know when BCAX announces revenue.

BCAX Revenue History By Year

BCAX Yearly RevenueBCAX RevenueBCAX ChangeBCAX Revenue Growth
2024-12-31$0.00N/AN/A
2023-12-31$0.00N/AN/A
2022-12-31$0.00N/AN/A

1 of 1

Bicara Therapeutics Revenue FAQ

What was BCAX's revenue last quarter?

Bicara Therapeutics (NASDAQ: BCAX) reported Q4 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Bicara Therapeutics's revenue was $0.00.

What was Bicara Therapeutics's revenue in 2024?

Bicara Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.

How much does Bicara Therapeutics make in a day?

Based on Bicara Therapeutics annual revenue for the past two years, BCAX makes an average of $0.00 per day.

What was Bicara Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Bicara Therapeutics's revenue has grown null year over year. Bicara Therapeutics's revenue in the past year totaled $0.00.

How much does Bicara Therapeutics make in a year?

Bicara Therapeutics's revenue by year for the past two years is:
  • Bicara Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $0.00, a N/A decrease year over year.
  • Bicara Therapeutics's annual revenue for Dec 31, 2023 was $0.00, a N/A decrease from 2022.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.